glp-1 vs gip-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal? Potential Use of GLP-1 and
Description
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk was published in Nature Cardiovascular Research in April 2024
After 2-4 weeks, nausea commonly decreases noticeably as your digestive system adjusts to the drug's mechanism
In other words, GLP-1 is a subset of peptides, not a separate category
During GLP-1 use, the body often becomes more efficient at handling glucose
P.TianS
As your body changes, your strategies will need to adapt
